These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1001 related items for PubMed ID: 26092278

  • 1. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T, Hasegawa T, Ochiai K, Takizawa K, Umezawa S, Kuramoto H, Ohmura M, Kubushiro K, Arai H, Sakamoto M, Motoyama T, Watanabe K, Aoki D.
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [Abstract] [Full Text] [Related]

  • 2. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Dec; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 3. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
    Persson M, Elfström KM, Olsson SE, Dillner J, Andersson S.
    PLoS One; 2015 Dec; 10(6):e0127444. PubMed ID: 26083247
    [Abstract] [Full Text] [Related]

  • 4. High risk HPV testing in the triage of repeat ASC-US and LSIL.
    Veijalainen O, Tuomisaari S, Luukkaala T, Mäenpää J.
    Acta Obstet Gynecol Scand; 2015 Sep; 94(9):931-6. PubMed ID: 26053676
    [Abstract] [Full Text] [Related]

  • 5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 6. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M, McMenamin M, McDowell A.
    Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 10. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 15. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 23; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H, Lin A, Shao X, Shi W, Zhang Y, Yan W.
    Oncotarget; 2016 Dec 13; 7(50):83775-83783. PubMed ID: 27626178
    [Abstract] [Full Text] [Related]

  • 17. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Lorenzi AT, Fregnani JH, Possati-Resende JC, Antoniazzi M, Scapulatempo-Neto C, Syrjänen S, Villa LL, Longatto-Filho A.
    Cancer Cytopathol; 2016 Aug 13; 124(8):581-8. PubMed ID: 27070446
    [Abstract] [Full Text] [Related]

  • 18. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS, Lorenzi AT, Scapulatempo-Neto C, Stein MD, Resende JC, Antoniazzi M, Villa LL, Levi JE, Longatto-Filho A, Fregnani JH.
    PLoS One; 2016 Aug 13; 11(10):e0164892. PubMed ID: 27764154
    [Abstract] [Full Text] [Related]

  • 19. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L, Hong Z, Gao H, Qiu L, Di W.
    Cytopathology; 2019 Jul 13; 30(4):419-425. PubMed ID: 31069857
    [Abstract] [Full Text] [Related]

  • 20. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R, Berkhof J, Dijkstra MG, van Kemenade FJ, Snijders PJ, Heideman DA, Meijer CJ.
    J Clin Virol; 2015 Jun 13; 67():59-66. PubMed ID: 25959161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.